Abstract:Congenital single-ventricle heart defects (SVHDs) are life-threatening conditions in newborns, where one of the heart's ventricular chambers is severely underdeveloped. While medical advancements have improved survival rates, many SVHD patients still suffer lifelong cardiac complications and comorbidities. Clinical diagnosis of fetal SVHD occurs at around 20 weeks of gestation through echocardiogram. In this study, we aimed to identify novel maternal blood biomarkers that could signal SVHD development in fetuses. The study's premise is based on the limited regenerative capacity of adult human cardiomyocytes, like those in pregnant mothers, compared to the extensive proliferation seen in fetal cardiomyocytes that form the functional heart. We hypothesized small signaling molecules secreted by proliferating fetal cardiomyocytes enter the maternal circulatory system and could indicate abnormal ventricular growth in SVHD-affected fetuses. Both clinical and in vitro approaches were employed to identify potential cell-free miRNAs released by the developing fetal heart into maternal circulation. Blood plasma samples from pregnant women carrying healthy and SVHD-affected fetuses were screened for differentially expressed cell-free miRNAs and were compared with those from the supernatants of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) grown from healthy and SVHD donors. This comparative approach led to the identification of an miRNA panel (miR-487b, miR-433, mi-134, and miR-889) that were elevated in pregnant women carrying SVHD-affected fetuses and in proliferating iPSC-CMs from SVHD patients compared to healthy controls (p.adj<0.05). From this panel, forced-expression of miR-487b and mir-134 modulated the proliferation profiles of human cardiomyocytes in vitro . Results from this study establish these circulating cell-free miRNAs in maternal blood as potential non-invasive biomarkers for predicting abnormal fetal cardiac development leading to SVHDs. These findings could potentially revolutionize SVHD screening as an alternative diagnostic tool to echocardiogram.

MicroRNA Biomarkers for Early Detection of Embryonic Malformations in Pregnancy

Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects.

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

Identification of Maternal Serum Micrornas As Novel Non-Invasive Biomarkers for Prenatal Detection of Fetal Congenital Heart Defects

Expression Profile of Maternal Circulating Micrornas As Non-Invasive Biomarkers for Prenatal Diagnosis of Congenital Heart Defects.

Circulating MicroRNAs As Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy

Potential candidate maternal serum miRNAs for the diagnosis of fetal congenital heart disease

Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities

Exosomal miRNAs in prenatal diagnosis: Recent advances

MicroRNAs secreted by human embryos could be potential biomarkers for clinical outcomes of assisted reproductive technology

MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy

MicroRNA–mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers

Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects

The Role in Pathomechanism and Diagnostic Significance

Maternal Circulating Exosomal miRNAs as Non-invasive Biomarkers for the Prediction of Fetal Ventricular Septal Defect

Detection Of Placental Mirnas In Maternal Plasma

Early Second-Trimester Serum MicroRNAs As Potential Biomarker for Nondiabetic Macrosomia

Differential Expression of Circulating Mirnas in Maternal Plasma in Pregnancies with Fetal Macrosomia

A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia

Elevated Cell-Free RNA in Maternal Circulation During Single Ventricle Heart Defect Pregnancies Dysregulate Human Cardiomyocyte Proliferation

MicroRNA-873 is a Potential Serum Biomarker for the Detection of Ectopic Pregnancy.